BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19426821)

  • 1. A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
    Abujamra AL; Almeida VR; Brunetto AL; Schwartsmann G; Roesler R
    Cell Biol Int; 2009 Aug; 33(8):899-903. PubMed ID: 19426821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
    Jaeger M; Ghisleni EC; Fratini L; Brunetto AL; Gregianin LJ; Brunetto AT; Schwartsmann G; de Farias CB; Roesler R
    Childs Nerv Syst; 2016 Jan; 32(1):61-4. PubMed ID: 26590027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
    Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
    Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bombesin induces angiogenesis and neuroblastoma growth.
    Kang J; Ishola TA; Baregamian N; Mourot JM; Rychahou PG; Evers BM; Chung DH
    Cancer Lett; 2007 Aug; 253(2):273-81. PubMed ID: 17383815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of low and high doses of the gastrin-releasing peptide receptor antagonist RC-3095 on memory consolidation in the hippocampus: possible involvement of the GABAergic system.
    Dantas Ados S; Luft T; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2006 Sep; 27(9):2307-12. PubMed ID: 16650508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
    Kiaris H; Schally AV; Sun B; Armatis P; Groot K
    Oncogene; 1999 Nov; 18(50):7168-73. PubMed ID: 10597318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of proliferation of U138-MG glioblastoma cells by gastrin-releasing peptide in combination with agents that enhance cAMP signaling.
    Farias CB; Lima RC; Lima LO; Flores DG; Meurer L; Brunetto AL; Schwartsmann G; Roesler R
    Oncology; 2008; 75(1-2):27-31. PubMed ID: 18719351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
    Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gastrin-releasing peptide receptor antagonist blocks D-amphetamine-induced hyperlocomotion and increases hippocampal NGF and BDNF levels in rats.
    Kauer-Sant'Anna M; Andreazza AC; Valvassori SS; Martins MR; Barbosa LM; Schwartsmann G; Roesler R; Quevedo J; Kapczinski F
    Peptides; 2007 Jul; 28(7):1447-52. PubMed ID: 17629354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines.
    Yano T; Pinski J; Groot K; Schally AV
    Cancer Res; 1992 Aug; 52(16):4545-7. PubMed ID: 1643647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibition prevents the impairing effects of hippocampal gastrin-releasing peptide receptor antagonism on memory consolidation and extinction.
    Petry FS; Dornelles AS; Lichtenfels M; Valiati FE; de Farias CB; Schwartsmann G; Parent MB; Roesler R
    Behav Brain Res; 2016 Jul; 307():46-53. PubMed ID: 27025446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
    Stangelberger A; Schally AV; Varga JL; Zarandi M; Szepeshazi K; Armatis P; Halmos G
    Clin Cancer Res; 2005 Jan; 11(1):49-57. PubMed ID: 15671527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin-releasing peptide receptors regulate proliferation of C6 Glioma cells through a phosphatidylinositol 3-kinase-dependent mechanism.
    Flores DG; de Farias CB; Leites J; de Oliveira MS; Lima RC; Tamajusuku AS; Di Leone LP; Meurer L; Brunetto AL; Schwartsmann G; Lenz G; Roesler R
    Curr Neurovasc Res; 2008 May; 5(2):99-105. PubMed ID: 18473825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095).
    Sotomayor S; Muñoz-Moreno L; Carmena MJ; Schally AV; Sánchez-Chapado M; Prieto JC; Bajo AM
    Int J Cancer; 2010 Oct; 127(8):1813-22. PubMed ID: 20099275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase.
    Taglia L; Matusiak D; Matkowskyj KA; Benya RV
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G182-90. PubMed ID: 16920698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC; Fleischmann A; Waser B; Rehmann R
    Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an antagonist of the gastrin-releasing peptide receptor in an animal model of uveitis.
    Pereira DV; Steckert AV; Mina F; Petronilho F; Roesler R; Schwartsmann G; Ritter C; Dal-Pizzol F
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5300-3. PubMed ID: 19516017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord.
    Sun YG; Chen ZF
    Nature; 2007 Aug; 448(7154):700-3. PubMed ID: 17653196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.